POSC23 Reductions in Migraine and Headache Days with Quarterly and Monthly Fremanezumab in Adult Patients with Migraine in a US Real-World Setting
Abstract
Authors
J Cohen S Thompson R Ayyagari M Driessen M Seminerio K Carr E Yim